{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T03:44:51Z","timestamp":1793677491669,"version":"4.5.1"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1097\/olq.0b013e3182953ce0","type":"journal-article","created":{"date-parts":[[2013,6,11]],"date-time":"2013-06-11T12:26:28Z","timestamp":1370953588000},"page":"534-538","source":"Crossref","is-referenced-by-count":23,"title":["Incidence of Genital Warts in Adolescents and Young Adults in an Integrated Health Care Delivery System in the United States Before Human Papillomavirus Vaccine Recommendations"],"prefix":"10.1097","volume":"40","author":[{"given":"Deepa R.","family":"Camenga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen F.","family":"Dunne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayur M.","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julianne","family":"Gee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauri E.","family":"Markowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajit","family":"DeSiliva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola P.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210213","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.puhe.2011.01.016","article-title":"Appraisal of the burden of genital warts from a healthcare and individual patient perspective.","volume":"125","author":"Scarbrough Lefebvre","year":"2011","journal-title":"Public health"},{"key":"R2-4-20210213","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1258\/ijsa.2008.008412","article-title":"Shame on youthe psychosocial impact of genital warts.","volume":"20","author":"Jeynes","year":"2009","journal-title":"Int J STD AIDS"},{"key":"R3-4-20210213","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3109\/01674820903564440","article-title":"The psychological impact of illness among women experiencing human papillomavirus-related illness or screening interventions.","volume":"31","author":"Wang","year":"2010","journal-title":"J Psychosom Obstet Gynaecol"},{"key":"R4-4-20210213","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1363\/3601104","article-title":"The estimated direct medical cost of sexuality transmitted diseases among American Youth, 2000.","volume":"36","author":"Chesson","year":"2004","journal-title":"Perspect Sex Reprod Health"},{"key":"R5-4-20210213","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1086\/375074","article-title":"The health and economic burden of genital warts in a set of private health plans in the United States.","volume":"36","author":"Insinga","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R6-4-20210213","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1086\/521192","article-title":"Genital human papillomavirus infection in men: Incidence and risk factors in a cohort of university students.","volume":"196","author":"Partridge","year":"2007","journal-title":"J Infect Dis"},{"key":"R7-4-20210213","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1067\/mob.2003.164","article-title":"Clinical findings among young women with genital human papillomavirus infection.","volume":"188","author":"Mao","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"R8-4-20210213","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1086\/591095","article-title":"Age-specific prevalence, incidence, and duration of human papillomavirus infections in a cohort of 290 US men.","volume":"198","author":"Giuliano","year":"2008","journal-title":"J Infect Dis"},{"key":"R9-4-20210213","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1086\/521632","article-title":"Risk factors for anogenital human papillomavirus infection in men.","volume":"196","author":"Nielson","year":"2007","journal-title":"J Infect Dis"},{"key":"R10-4-20210213","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/01.olq.0000145851.76025.ad","article-title":"Rate and predictors of new genital warts claims and genital warts-related healthcare utilization among privately insured patients in the United States.","volume":"31","author":"Koshiol","year":"2004","journal-title":"Sex Transm Dis"},{"issue":"RR-2","key":"R11-4-20210213","first-page":"1","article-title":"Quadrivalent human papillomavirus vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"56","author":"Markowitz","year":"2007","journal-title":"MMWR Recomm Rep"},{"key":"R12-4-20210213","first-page":"1705","article-title":"Recommendations on the use of quadrivalent human papillomavirus vaccine in malesAdvisory Committee on Immunization Practices (ACIP), 2011. MMWR.","volume":"60","year":"2011","journal-title":"Morb Mortal Wkly Rep"},{"key":"R13-4-20210213","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0140-6736(10)62342-2","article-title":"Incidence and clearance of genital human papillomavirus infection in men (HIM): A cohort study.","volume":"377","author":"Giuliano","year":"2011","journal-title":"Lancet"},{"key":"R14-4-20210213","doi-asserted-by":"crossref","first-page":"c3493","DOI":"10.1136\/bmj.c3493","article-title":"Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: Randomised controlled trial.","volume":"341","author":"Dillner","year":"2010","journal-title":"BMJ"},{"key":"R15-4-20210213","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1056\/NEJMoa0909537","article-title":"Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males.","volume":"364","author":"Giuliano","year":"2011","journal-title":"N Engl J Med"},{"key":"R16-4-20210213","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1185\/03007990903136378","article-title":"Assessing incidence and economic burden of genital warts with data from a US commercially insured population.","volume":"25","author":"Hoy","year":"2009","journal-title":"Curr Med Res Opin"},{"key":"R17-4-20210213","first-page":"1","article-title":"Natural history of genital warts.","volume":"47","author":"Oriel","year":"1971","journal-title":"Br J Vener Dis"},{"key":"R18-4-20210213","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1086\/427557","article-title":"Development and duration of human papillomavirus lesions, after initial infection.","volume":"191","author":"Winer","year":"2005","journal-title":"J Infect Dis"},{"key":"R19-4-20210213","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2105\/AJPH.89.6.825","article-title":"Sexual mixing patterns in the spread of gonococcal and chlamydial infections.","volume":"89","author":"Aral","year":"1999","journal-title":"Am J Public Health"},{"key":"R20-4-20210213","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1471-2334-8-76","article-title":"Estimation of the incidence of genital warts and the cost of illness in Germany: A cross-sectional study.","volume":"8","author":"Hillemanns","year":"2008","journal-title":"BMC Infect Dis"},{"key":"R21-4-20210213","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/00007435-200111000-00006","article-title":"Condylomata acuminata (genital warts): Patient demographics and treating physicians.","volume":"28","author":"Fleischer","year":"2001","journal-title":"Sex Transm Dis"},{"key":"R22-4-20210213","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/archderm.1984.01650400051012","article-title":"Condyloma acuminatum in Rochester, Minn., 1950-1978. I. Epidemiology and clinical features.","volume":"120","author":"Chuang","year":"1984","journal-title":"Arch Dermatol"},{"issue":"suppl 2","key":"R23-4-20210213","doi-asserted-by":"crossref","first-page":"S210","DOI":"10.1086\/342109","article-title":"External genital warts: Diagnosis, treatment, and prevention.","volume":"35","author":"Wiley","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R24-4-20210213","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1473-3099(10)70225-5","article-title":"Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: Analysis of national sentinel surveillance data.","volume":"11","author":"Donovan","year":"2011","journal-title":"Lancet Infect Dis"},{"issue":"suppl 1","key":"R25-4-20210213","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/j.ypmed.2011.08.015","article-title":"Adolescent and young adult HPV vaccination in Australia: Achievements and challenges.","volume":"53","author":"Garland","year":"2011","journal-title":"Prev Med"},{"key":"R26-4-20210213","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/sextrans-2011-050234","article-title":"The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme.","volume":"87","author":"Read","year":"2011","journal-title":"Sex Transm Infect"},{"key":"R27-4-20210213","doi-asserted-by":"crossref","first-page":"833","DOI":"10.2105\/AJPH.2011.300465","article-title":"Evidence of human papillomavirus vaccine-effectiveness in reducing genital warts: An analysis of California Public Family Planning Administrative claims data, 2007-2010.","volume":"102","author":"Bauer","year":"2012","journal-title":"Am J Public Health"},{"key":"R28-4-20210213","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1258\/0956462981921143","article-title":"An international survey of patients with genital warts: Perceptions regarding treatment and impact on lifestyle.","volume":"9","author":"Maw","year":"1998","journal-title":"Int J STD AIDS"},{"key":"R29-4-20210213","first-page":"10","article-title":"Where do people go for treatment of sexually transmitted diseases Fam Plan P","volume":"31","author":"Brackbill","year":"1999","journal-title":"erspect"},{"key":"R30-4-20210213","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S1054-139X(01)00193-8","article-title":"Adolescent HMO enrollees utilization of out of plan services.","volume":"28","author":"Civic","year":"2001","journal-title":"J Adolesc Health"}],"container-title":["Sexually Transmitted Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/OLQ.0b013e3182953ce0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T04:58:43Z","timestamp":1620968323000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007435-201307000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/olq.0b013e3182953ce0","relation":{},"ISSN":["0148-5717"],"issn-type":[{"value":"0148-5717","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}